Shares of The Dow Chemical Company (NYSE:DOW) are on a recovery track as they have regained 35.53% since bottoming out at $47.51 on Jul. 06, 2016. Meanwhile, due to an ongoing pressure which caused a decline of almost -0.54% in the past five days, the stock price is now up 12.53% so far on the year — still in strong territory. In this case, shares are down -1.57% from $65.42 , the 52-week high touched on Jun. 14, 2017, and are keeping their losses at 23.38% for the past 12 months.Is It Worth the Risk?
Brokerage houses, on average, are recommending investors to buy The Dow Chemical Company (DOW)’s shares projecting a $71.83 target price. What do this target means? Price targets reflect what the analyst believes a stock will be worth four quarters into the future. Are investors supposed to sell when the stock hits the target? Price targets frequently change, depending on the outlook for a company’s earnings. Sometimes it may seem like it, but analysts don’t just pull their price targets out of thin air. Typically, they estimate what the company’s earnings and cash flow will be for the next couple of years, and then apply a ratio – such as a price-to-earnings ratio – to those estimates to determine what the future stock price should theoretically be.Revenue Growth Rates
DOW’s revenue has declined at an average annualized rate of about -4.3% during the past five years. However, the company’s most recent quarter increase of 23.6% looks attractive.
While there are a number of profitability ratios that measure a company’s ability to generate profit from the sales or services it provides, one of the most important is the net profit margin. It tells us what percentage of revenue a company keeps after all its bills are paid. While the higher this number is, the better, there is no gold standard. That’s why this number shouldn’t be looked at in isolation, but should be compared to a company’s peer group as well as its sector. Currently, The Dow Chemical Company net profit margin for the 12 months is at 9.95%. Comparatively, the peers have a net margin 8.09%, and the sector’s average is 13.1%. In that light, it seems in good position compared to its peers but weakness can be witnessed when compared with the sector.
TG Therapeutics, Inc. (NASDAQ:TGTX) is another stock that is grabbing investors attention these days. Its shares have trimmed -27.69% since hitting a peak level of $15.35 on Jun. 05, 2017. Meanwhile, due to a recent pullback which led to a fall of almost 0% in the past one month, the stock price is now outperforming with 138.71% so far on the year — still in strong zone. In this case, shares are 170.73% higher from $4.1, the worst price in 52 weeks suffered on Jan. 24, 2017, and are keeping their losses at 124.24% for the past six months.Trading The Odds
The good news is there’s still room for the share price to grow. At recent closing price of $11.1, TGTX has a chance to add $13.04 or 117.48% in 52 weeks, based on mean target price ($24.14) placed by analysts.The analyst consensus opinion of 1.4 looks like a buy. It has a 36-month beta of 1.2 , so you might be in for a bumpy ride.EPS Growth Rates
For the past 5 years, TG Therapeutics, Inc.’s EPS growth has been nearly 40.9%. Sure, the percentage is encouraging but more headwinds are coming as looking out over a next 5-year period, analysts expect the company to see its earnings go down by 0%, annually.Is it turning profits into returns?
Two other important profitability ratios for investors to know are both returns-based ratios that measure a company’s ability to create wealth for shareholders. They are return on equity and return on assets. Return on equity measures is a company’s ability to turn an investor’s equity into profit. The higher the return on equity, the better job a company is at optimizing the investment made on shareholders’ behalf. TG Therapeutics, Inc.’s ROE is -96.73%, while industry’s is -10.42%. The average ROE for the sector stands at -4.09%.
Return on assets, on the other hand, measures a company’s ability to turn assets such as cash, buildings, equipment, or inventory into more assets. TGTX’s ROA is -82.51%, while industry’s average is -5.4%. As with any return, the higher this number the better. However, it, too, needs to be taken into the context of a company’s peer group as well as its sector. The average return on assets for companies in the same sector is -10.83.